ECB increases out-of-competition anti-doping tests with focus on short-form cricket

New data reveals rapid growth in number of drug tests administered on cricketers

Matt Roller11-Mar-2020The number of out-of-competition drugs tests administered on cricketers by UK Anti-Doping (UKAD) has grown tenfold in the past five years, according to new data obtained by ESPNcricinfo.The new figures, revealed via Freedom of Information requests, demonstrate an increase in the total number of tests administered annually on cricketers under the ECB’s jurisdiction from 126 in 2013-14 to 315 in 2018-19*, and confirm the governing body’s increased efforts to ensure cricket remains a clean sport.ALSO READ: Fines doubled, 21-day ban scrapped as ECB update recreational drug policyFrom 2013 to 2017, cricket was not considered a high-risk sport by UKAD, the national anti-doping body, but discussions two years ago and an increase in UKAD’s capacity due to additional government funding led to cricket receiving a free ‘public interest’ test allocation. No player tested positive for any performance-enhancing substance in 2019.Increased professionalism and an awareness that the proliferation of T20 leagues has enhanced the potential benefits of doping have both prompted the extension of the ECB’s programme. This year, short-form cricket makes up a greater proportion of the English summer on account of the Hundred’s inaugural season, suggesting that the number of tests administered will continue to grow.